PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+36.97%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$390M
AUM Growth
+$390M
(+3.3%)
Cap. Flow
-$61.3M
Cap. Flow
% of AUM
-15.71%
Top 10 Holdings %
Top 10 Hldgs %
30.29%
Holding
100
New
16
Increased
29
Reduced
38
Closed
17
Top Buys
| 1 |
Schrodinger
SDGR
|
$8.4M |
| 2 |
Arrowhead Research
ARWR
|
$5.15M |
| 3 |
DexCom
DXCM
|
$4.42M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$4.26M |
| 5 |
Avantor
AVTR
|
$4.25M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$12.7M |
| 2 |
Merck
MRK
|
$10.4M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$9.03M |
| 4 |
Masimo
MASI
|
$8.26M |
| 5 |
Edwards Lifesciences
EW
|
$6.56M |
Sector Composition
| 1 | Healthcare | 92.05% |
| 2 | Technology | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DexCom
DXCM
$29.5B
| $15.4M | 3.93% | 41,528 +11,959 | +40% | +$4.42M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12.9M | 3.29% | 175,712 -61,242 | -26% | -$4.48M |
|
3
Vericel Corp
VCEL
$1.83B
| $12.4M | 3.17% | 400,743 -49,657 | -11% | -$1.53M |
|
|
4
Schrodinger
SDGR
$1.44B
| $12.4M | 3.17% | 156,085 +106,085 | +212% | +$8.4M |
|
5
Aclaris Therapeutics
ACRS
$209M
| $12.1M | 3.11% | 1,875,336 +32,675 | +2% | +$211K |
|
6
Natera
NTRA
$23.1B
| $12M | 3.08% | 120,867 -54,294 | -31% | -$5.4M |
|
7
Danaher
DHR
$147B
| $10.6M | 2.71% | 47,687 -17,321 | -27% | -$3.85M |
|
8
IQVIA
IQV
$32.4B
| $10.4M | 2.67% | 58,224 +5,716 | +11% | +$1.02M |
|
9
Humana
HUM
$36.5B
| $10.2M | 2.61% | 24,808 -1,701 | -6% | -$698K |
|
10
Charles River Laboratories
CRL
$8.04B
| $9.91M | 2.54% | 39,666 -339 | -0.8% | -$84.7K |
|
|
11
Arrowhead Research
ARWR
$3.05B
| $9.76M | 2.5% | 127,171 +67,171 | +112% | +$5.15M |
|
|
GWPH
12
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $9.41M | 2.41% | 81,573 +31,573 | +63% | +$3.64M |
|
|
GNMK
13
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.02M | 2.31% | 617,722 +137,523 | +29% | +$2.01M |
|
|
CTLT
14
DELISTED
CATALENT, INC.
CTLT
| $8.75M | 2.24% | 84,119 -5,897 | -7% | -$614K |
|
|
CDMO
15
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $8.65M | 2.22% | 749,511 +265,264 | +55% | +$3.06M |
|
16
UnitedHealth
UNH
$281B
| $8.41M | 2.16% | 23,993 +2,992 | +14% | +$1.05M |
|
17
Insulet
PODD
$23.9B
| $7.82M | 2% | 30,587 -1,916 | -6% | -$490K |
|
18
Kodiak Sciences
KOD
$478M
| $7.33M | 1.88% | 49,913 -42,820 | -46% | -$6.29M |
|
|
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $7.3M | 1.87% | 331,513 +5,650 | +2% | +$124K |
|
20
Alphatec Holdings
ATEC
$2.35B
| $7.3M | 1.87% | 502,655 +50,983 | +11% | +$740K |
|
|
TPTX
21
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $7.24M | 1.85% | 59,377 -50,958 | -46% | -$6.21M |
|
|
ICAD
22
DELISTED
iCAD Inc
ICAD
| $7.16M | 1.84% | 542,602 -39,150 | -7% | -$517K |
|
|
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
| $6.71M | 1.72% | 52,458 +2,442 | +5% | +$312K |
|
|
SPNE
24
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $6.54M | 1.68% | 374,945 +6,132 | +2% | +$107K |
|
25
Arcus Biosciences
RCUS
$1.13B
| $6.02M | 1.54% | 231,758 -3,280 | -1% | -$85.1K |
|